Mireya Paulina Velasquez

Author

St. Jude Children's Research Hospital ORCID

Also Known As

M Paulina Velasquez, M Velásquez, M. Paulina Velasquez, M.Paulina Velasquez, Mireya P Velasquez, Mireya P. Velasquez, Mireya Paulina Velasquez, Mireya Velasquez

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital Baylor College of Medicine Texas Children's Hospital Houston Methodist Methodist Hospital

About

Mireya Paulina Velasquez is an author at St. Jude Children's Research Hospital specializing in immunology, medicine, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	139
2	Immunology	5	5	139
3	Cell Biology	4	4	76
4	Health Sciences	2	2	90
5	Cellular Therapies	2	2	90

Mireya Paulina Velasquez

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen, Science Translational Medicine	2021	302
Engager T Cells: A New Class of Antigen-specific T Cells That Redirect Bystander T Cells Kota Iwahori, Sunitha Kakarla, Mireya Paulina Velasquez, Molecular Therapy	2014	99
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia Challice L. Bonifant, Árpád Szöőr, David Torres, Molecular Therapy	2016	80
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells Nikhil Hebbar, Rebecca Epperly, Abishek Vaidya, Nature Communications	2022	80
Engineering naturally occurring CD7− T cells for the immunotherapy of hematological malignancies Abdullah Freiwan, Jaquelyn T. Zoine, Jeremy Chase Crawford, Blood Cell TherapyT-regulatory CellImmunologyCd4 T Cell ResponsesHematological Malignancies	2022	63
Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages Taylor L. Wilson, Hyunjin Kim, Ching‐Heng Chou, Cancer Discovery	2022	57
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies Mireya Paulina Velasquez, David Torres, Kota Iwahori, Scientific Reports	2016	56
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL Aimee C. Talleur, Amr Qudeimat, Jean‐Yves Métais, Blood Advances	2022	55
Erythrocytapheresis in children with sickle cell disease and acute chest syndrome Mireya Paulina Velasquez, Mary Michelle Mariscalco, Stuart L. Goldstein, Pediatric Blood & Cancer	2009	48
Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial Swati Naik, Renee Madden, Amanda Lipsitt, Blood	2022	44

Page 1